November 26, 2015
FDA may withhold approval of Dr. Reddy’s new applications or supplements listing
The FDA said that, until Dr. Reddy’s complete all corrections and FDA confirms its compliance with CGMP, it may withhold approval of any new applications or supplements listing Dr. Reddy as a drug product or API manufacturer.